Macrophage and microglial plasticity in the injured spinal cord

Macrophage and microglial plasticity in the injured spinal cord

NSC 16551 No. of Pages 8 5 September 2015 Please cite this article in press as: David S et al. Macrophage and microglial plasticity in the injured s...

528KB Sizes 4 Downloads 33 Views

NSC 16551

No. of Pages 8

5 September 2015 Please cite this article in press as: David S et al. Macrophage and microglial plasticity in the injured spinal cord. Neuroscience (2015), http://dx.doi.org/ 10.1016/j.neuroscience.2015.08.064 1

Neuroscience xxx (2015) xxx–xxx

2

NEUROSCIENCE FOREFRONT REVIEW

4

MACROPHAGE AND MICROGLIAL PLASTICITY IN THE INJURED SPINAL CORD

5

S. DAVID, * A. D. GREENHALGH AND A. KRONER

3

6 7 8

Effects of phagocytosis of RBCs and uptake of iron by IL-4 and LPS-stimulated macrophages Conclusion Acknowledgments References

Centre for Research in Neuroscience, The Research Institute of the McGill University Health Centre, 1650 Cedar Ave., Montreal, Quebec H3G 1A4, Canada

21

00 00 00 00

22 23 24 25 26

9

Abstract—Macrophages in the injured spinal cord arise from resident microglia and from infiltrating peripheral myeloid cells. Microglia respond within minutes after central nervous system (CNS) injury and along with other CNS cells signal the influx of their peripheral counterpart. Although some of the functions they carry out are similar, they appear to be specialized to perform particular roles after CNS injury. Microglia and macrophages are very plastic cells that can change their phenotype drastically in response to in vitro and in vivo conditions. They can change from proinflammatory, cytotoxic cells to anti-inflammatory, prorepair phenotypes. The microenvironment of the injured CNS importantly influences macrophage plasticity. This review discusses the phagocytosis and cytokine-mediated effects on macrophage plasticity in the context of spinal cord injury. Ó 2015 Published by Elsevier Ltd. on behalf of IBRO.

27

Key words: microglia, macrophage, spinal cord injury, macrophage activation, phagocytosis, tumor necrosis factor, inflammation. 10 11 12 13 14 15 16 17 18 19 20

Contents Introduction Early response of microglia and monocyte-derived macrophage to injury Microglia and macrophage activation Phagocytosis modulates macrophage phenotype Effects of myelin phagocytosis by LPS-stimulated macrophages Effects of phagocytosis of apoptotic neutrophils by LPS-stimulated macrophages

00 00 00 00 00 00

*Corresponding author. Address: Centre for Research in Neuroscience, The Research Institute of the McGill University Health Centre, Livingston Hall, Room L7-210, 1650 Cedar Ave., Montreal, Quebec H3G 1A4, Canada. E-mail address: [email protected] (S. David). Abbreviations: BMDMs, bone marrow-derived macrophages; Ca2+, calcium; CNS, central nervous system; EAE, encephalomyelitis; FACS, fluorescence-activated cell sorting; iNOS, inducible nitric oxide synthase; MK2, protein kinase 2; MS, multiple sclerosis; RBCs, red blood cells. http://dx.doi.org/10.1016/j.neuroscience.2015.08.064 0306-4522/Ó 2015 Published by Elsevier Ltd. on behalf of IBRO. 1

INTRODUCTION

28

Macrophages play a central role in the response to central nervous system (CNS) injury and originate from two sources, one from the resident microglial population and the other of myeloid origin that infiltrate the injured CNS from the peripheral circulation. Many tissues have resident macrophages that arise from either the yolk sac, fetal liver or hematopoietic system. Microglia the resident tissue macrophages of the CNS, arise from cells originating in the yolk sac that infiltrate the brain early during embryonic development (E9.5) (Alliot et al., 1999; Ginhoux et al., 2010; Ransohoff and Cardona, 2010) and the spinal cord by E10.4 (Rigato et al., 2011). They populate the CNS and are maintained throughout life by proliferation and by their longevity (Lawson et al., 1992; Alliot et al., 1999; Ajami et al., 2007; Ginhoux et al., 2010). In extreme experimental conditions when microglia are completely depleted from the adult CNS, they appear to be replenished by CNS resident progenitors (Elmore et al., 2014). It is not clear at present whether this occurs in the normal or damaged CNS where cells can be replaced by proliferation of microglia in the vicinity. In some gray matter regions such as the cerebral cortex they show ‘‘tiling” and occupy exclusive domains but their morphology depends largely on the cytoarchitecture of the CNS region in which they reside (Lawson et al., 1990). In the normal adult CNS, microglia have a branching morphology and are relatively quiescent in terms of cytokine production and immune function. However, their branching processes show short distance motility and are constantly surveying the microenvironment for changes in homeostatic conditions. The range of motility of microglia processes is between 2 and 8 lm within 1–2 min (Davalos et al., 2005; Nimmerjahn et al., 2005). In contrast, astrocytes show process extension and retraction in the range of 8–10 lm over a 10-min period (Haber et al., 2006). Glial cells in general therefore survey and monitor their local environment, and thus respond rapidly to perturbations.

29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66

NSC 16551

No. of Pages 8

5 September 2015

2 67 68 69 70 71 72 73 74 75 76 77 78 79 80

81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125

S. David et al. / Neuroscience xxx (2015) xxx–xxx

Important functions of microglia and macrophages in response to CNS injury are to clear damaged tissue, fight infections and restore tissue homeostasis. In this review we will focus on how phagocytosis regulates macrophage phenotype to either a protective or cytotoxic state. We will discuss how what macrophages phagocytose determines their activation phenotype. In other words ‘‘what they eat” determines ‘‘what they become”. We will also discuss how TNF importantly modulates these phenotypes in vitro and in vivo in the injured spinal cord, by keeping them in a prolonged proinflammatory, cytotoxic state, that is detrimental to recovery after injury. But first we will provide a brief review of the early responses of these cells to CNS injury.

EARLY RESPONSE OF MICROGLIA AND MONOCYTE-DERIVED MACROPHAGE TO INJURY Microglia in the normal CNS have the following antigenic phenotype: CD11b+, CD45low, CX3CR1high, Ly6Clow, Gr-1low (David and Kroner, 2011). They respond rapidly to injury and as shown by 2-photon live imaging after cortical micro-lesions, they redirect and extend cytoplasmic processes toward the lesion within 5 min and by 30 min form a dense network of cytoplasmic processes surrounding the lesion (Davalos et al., 2005; Hines et al., 2009). Preventing this acute microglial response leads to an increase in the size of the lesion (Hines et al., 2009). Thus, this early microglial response is protective, as it helps contain the expansion of the lesion in the acute phase. In the mammalian cortex where microglia are densely packed, the early injury-induced response to micro lesions mainly involves redirection and extension of cytoplasmic processes (Davalos et al., 2005; Hines et al., 2009). In some cases, such as in the spinal cord (Dibaj et al., 2010), and in mouse models of Alzheimer’s disease (Fuhrmann et al., 2010) translocation of microglial cell bodies also occurs. After traumatic brain injury, microglia located close to the glia limitans acquire a honeycomb morphology aligning their processes along the astrocytic junctions and are thought to serve a protective function, or they acquire a jellyfish morphology showing cell body movement and are involved in phagocytosis of dying astrocytes (Roth et al., 2014). Migration of microglial cell bodies toward the lesion site is seen in organisms in which microglia are sparsely distributed, such as in the developing zebrafish embryo (Sieger et al., 2012). The rapid extension of microglial processes toward the lesion is mediated by purinergic receptors (P2Y12R) binding to ATP released by damaged cells or from astrocytes (Davalos et al., 2005; Haynes et al., 2006; Dibaj et al., 2010). Nitric oxide may also contribute to the ATP-mediated microglial response (Dibaj et al., 2010). In places where microglia are sparsely distributed, those located at a distance from the lesion are attracted toward the lesion by glutamate released from damaged cells that induce calcium (Ca2+) influx and the spread of Ca2+ waves in astrocytes that leads to release of ATP (Sieger et al., 2012). The ATP gradient is sensed by microglia located at a distance via the P2Y12 receptors. Microglia

and other cells in the injured CNS (astrocytes, oligodendrocytes and neurons) express chemokines and cytokines within minutes after CNS damage, including CCL2, CCL3, GM-CSF, IL-1b and TNF (Pineau and Lacroix, 2007; David et al., 2012b). Damage-associated molecular patterns (DAMPs) released from dying cells, bind to tolllike receptors and induce NFjB activation and the expression of pro-inflammatory molecules, such as cytokines, cyclooxygenase-2, inducible nitric oxide synthase (iNOS) and matrix metalloproteinases (Piccinini and Midwood, 2010; Heiman et al., 2014; Katsumoto et al., 2014). These and other factors induce the influx of monocyte-derived macrophages from the circulation into the site of CNS damage. Microglia and the other resident cells of the CNS are therefore the ‘‘first responders” to any tissue perturbation. In the normal CNS, macrophages of myeloid origin, distinct from microglia, are found in the perivascular region, choroid plexus, and the meninges (Perry et al., 1985; Ransohoff and Cardona, 2010; David and Kroner, 2011). After CNS injury, signals from microglia and other CNS cells recruit monocyte-derived macrophages from the circulation to the injury CNS in a largely CCL2-dependent manner (Lassmann et al., 1993; Mildner et al., 2007). These CX3CR1low, Ly6C+, CCR2+ monocytes are actively recruited to sites of injury or disease and are referred to as ‘inflammatory macrophages’ (Geissmann et al., 2003). Experimental evidence indicates that these cells enter the damaged CNS but do not remain in the CNS permanently. For example, in mice with experimental autoimmune encephalomyelitis (EAE), monocytederived macrophages enter the spinal cord but are cleared 3 months later when the EAE lesions have resolved (Ajami et al., 2011). These monocyte-derived macrophages therefore complement the functions of the resident microglia in responding to acute disruption of the CNS. Using LysM-eGFP knock-in mice, in which peripheral myeloid cells (macrophages and neutrophils) are tagged, we and others have shown that after SCI, macrophages enter the injury site after 2–3 days (d), reach maximum numbers at 7–10 d, and persist in the injured cord for up to 42 d (Mawhinney et al., 2012; Greenhalgh and David, 2014). We have not examined longer time points after SCI. Peripheral-derived macrophages are more susceptible to apoptotic and necrotic cell death in vitro following phagocytosis as compared to microglia (Greenhalgh and David, 2014). Furthermore, in the contusion-injured spinal cord, infiltrating peripheral macrophages show more TUNEL-positive labeling than microglia (Greenhalgh and David, 2014). Whether this cell death is accompanied by a continuing influx of monocytederived macrophages weeks or months after SCI is currently not known. The turnover rate of microglia and the mechanisms that control their numbers in the normal and injured spinal cord are still not known.

126

MICROGLIA AND MACROPHAGE ACTIVATION

181

Microglia as well as macrophages that infiltrate into the injured CNS from the peripheral circulation, are highly plastic cells that can acquire very diverse activation

182

Please cite this article in press as: David S et al. Macrophage and microglial plasticity in the injured spinal cord. Neuroscience (2015), http://dx.doi.org/ 10.1016/j.neuroscience.2015.08.064

127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180

183 184

NSC 16551

No. of Pages 8

5 September 2015

S. David et al. / Neuroscience xxx (2015) xxx–xxx 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245

phenotypes, widely referred to as polarization. In the last 15 years, two polarization phenotypes resulting from stimulation with IFN-c or IL-4, referred to as M1 and M2 macrophages with phenotypes in-between; and additional subtypes of M2 (M2a, M2b and M2c) cells resulting from stimulation with other factors have been described (Gordon, 2003; Martinez et al., 2008). A panel of experts recently re-evaluated this classification which has become imprecise with widespread use, and recommend identifying the cells in vitro based on the activation stimulus, such as M(IFN-c) for IFN-c-stimulated cells, and M(IL-4) for IL-4-stimulated cells (Murray et al., 2014). They also defined a spectrum of activation states characterized by a variety of markers (expression of various cytokines, chemokines, cell surface and intracellular molecules and transcription factors) with activation by IL-4 (Arginase-1, CD204, STAT6, SOCS2) and IFN-c (TNF, IL-12, iNOS, STAT1, SOCS1) being at opposite ends of this spectrum (Murray et al., 2014). They suggested for describing in vitro work to state the activation stimulus, the source of the macrophages, full details of the culture conditions, and the use of multiple markers (Murray et al., 2014). The in vivo application is complicated by the fact that macrophages in vivo are influenced by multiple, often antagonistic stimuli. Recent transcriptional profiling of macrophages (Martinez et al., 2006), and microglia, hematogenous macrophages, and various types of tissue macrophages have revealed their tremendous heterogeneity (Hickman et al., 2013; Butovsky et al., 2014; Wes et al., 2015). The marked differences in the transcriptional profile of different macrophage and microglial populations from different regions of the CNS are not surprising as differences in the local tissue levels of cytokines, growth factors, extracellular matrix and other factors can influence their expression profile. Microglia and macrophages are designed to respond to a large variety of environmental signals. Recent transcriptome-based network analysis indicates that although IL-4 and IFN-c stimulation result in networks existing along a virtual bipolar axis with the two conditions at opposite ends, there is heterogeneity away from this axis when macrophages are stimulated in vitro with other factors (Xue et al., 2014). Network analysis of transcriptome data obtained from macrophages stimulated with a cocktail of factors (TNF, prostaglandin E2, TLR2 ligand) led to the identification of novel signature genes in pathways that differ from the M1/M2 axis (Xue et al., 2014). This work confirms and extends the current M1/M2 polarization and accounts for the greater heterogeneity in macrophage activation states. This is particularly relevant in vivo after injury or disease when macrophages are influenced by multiple, often antagonistic stimuli that include pro- and anti-inflammatory cytokines, chemokines, growth factors, TLR ligands, bioactive lipid mediators such as prostaglandins, extracellular matrix molecules, and others (Pineau and Lacroix, 2007; David et al., 2012a,b; Bartus et al., 2014). One way to assess changes in macrophage activation in vivo after SCI would be to do a transcriptome analysis of purified macrophages and microglia for different models of SCI in different species, and at different time points after

3

SCI. From this analysis, relevant genes can be identified that can then be assessed by anyone to probe for effects of treatment or other experimental manipulations. It is likely that this may include some of the genes associated with M1/M2 polarization. Changes in these genes between experimental and control groups can then be compared with network analysis to defined in vitro standards, such as macrophages or microglia treated with IL-4, IL-10, TNF or TLR ligands (Xue et al., 2014). Such comparisons would allow one to assess if the cells in the experimental group move from a region of the network considered pro-inflammatory or another part that is antiinflammatory and pro-repair. This analysis can extend from quantitative real-time PCR, fluorescence-activated cell sorting (FACS) or Western blot analysis. These changes can also be correlated with functional assays carried out in vitro, with microglia and macrophages purified by sorting and probed in cell death, neurite growth or phagocytosis assays (Kigerl et al., 2009; Greenhalgh and David, 2014; Kroner et al., 2014). The concept of regional clusters within a network denoting activation states that are either detrimental or pro-repair is useful because it would allow one to define hypotheses and assess if the experimental conditions being tested drive activation toward a particular regional cluster. Until such information becomes available, another focused approach to consider would be to screen for expression of molecules functionally relevant for inflammation in SCI, such as, TNF, IL-1b, IL-10, TGFb, STAT1, STAT6, STAT4, SOCS1, SOCS3 and other pro and anti-inflammatory cytokines and transcription factors, as well as some of the M(IL-4) markers (Arg-1, CD206) and M(LPS) markers (CD16/32, CD86, IL-12) that appear to be useful markers in mouse SCI (Kigerl et al., 2009; Shechter et al., 2013; Kroner et al., 2014). This analysis can be correlated with various functional assays carried out in vitro. One can then identify if the cells shift from a pro-inflammatory, cytotoxic to an anti-inflammatory, pro-repair state or vice versa. Although this review is focused on spinal cord injury, many of the issues discussed here are likely to be of relevance for brain trauma and possibly other neurological conditions. In addition to their role in macrophage polarization, these and other cytokines and chemokines also contribute to a wide range of glial and neuronal responses after SCI (Donnelly and Popovich, 2008; David and Kroner, 2011; Bastien and Lacroix, 2014).

246

PHAGOCYTOSIS MODULATES MACROPHAGE PHENOTYPE

292

Microglia phagocytose damaged material within the first day after SCI (Greenhalgh and David, 2014). When peripheral macrophages from the circulation influx into the injured spinal cord 2–3 d later, they immediately begin to phagocytose damaged axons and other debris, and by day 7, when they reach maximum numbers, they far outpace microglia in phagocytosing damaged material (Greenhalgh and David, 2014). It would appear that peripheral macrophages are much more specialized to phagocytose damaged tissue in the injured spinal cord or other regions of the injured CNS, than microglia. Within

294

Please cite this article in press as: David S et al. Macrophage and microglial plasticity in the injured spinal cord. Neuroscience (2015), http://dx.doi.org/ 10.1016/j.neuroscience.2015.08.064

247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291

293

295 296 297 298 299 300 301 302 303 304

NSC 16551

No. of Pages 8

5 September 2015

4 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322

323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363

S. David et al. / Neuroscience xxx (2015) xxx–xxx

a few days after injury after the influx of peripheral macrophages, microglia may revert back to maintaining normal tissue homeostasis and leave the business of phagocytosing damaged tissue and apoptotic cells to peripheral macrophages that enter the damaged area. Damaged tissue, apoptotic neutrophils, as well as red blood cells (RBCs) resulting from hemorrhage need to be phagocytosed after SCI to initiate tissue repair. Our in vitro work indicates that macrophages respond differently to phagocytosis of myelin, apoptotic neutrophils or RBCs (Kroner et al., 2014). In contrast, in vivo, the pro-inflammatory cytokine milieu can override some of the phagocytosisinduced changes in macrophage phenotype and promote pro-inflammatory, cytotoxic macrophages that have a detrimental effect on recovery after SCI (Kigerl et al., 2009; Kroner et al., 2014). In the following sections we will discuss the differences in the response of macrophages to phagocytosis of myelin, neutrophils, and RBCs. Effects of myelin phagocytosis by LPS-stimulated macrophages In vitro studies with human blood-derived macrophages activated with LPS showed that myelin phagocytosis reduced the mRNA expression of pro-inflammatory cytokines (IL-12 and TNF) and increased CCL18, a chemokine associated with ‘‘alternative” or M2 macrophage activation (Boven et al., 2006). We recently assessed the effects of myelin phagocytosis by LPS or LPS + IFN-c-stimulated bone marrow-derived macrophages (BMDMs) and microglia on the expression of a wider range of markers at the protein level by FACS analysis (Kroner et al., 2014). BMDMs stimulated by LPS and LPS + IFN-c, and microglia stimulated by LPS show a marked reduction in the LPS-induced increase in TNF as well as a small but significant reduction in CD16/32 (Fc c III R and Fc c II R) and CD86 both of which are increased from unstimulated levels by stimulation with LPS and LPS + IFN-c. In contrast to these markers, the scavenger receptor CD206 (MRC1) which is significantly decreased by LPS and LPS + IFN-c is markedly increased by myelin phagocytosis. Furthermore, myelin phagocytosis also reduces the stimulation- induced increase in Ly6C expression in BMDMs, and CX3CR1 expression in microglia. In addition, the increase in iNOS and reduction in arginase-1 induced in microglia by LPS is significantly reversed after myelin phagocytosis (Kroner et al., 2014). Increased expression of TNF and iNOS is associated with IFN-c stimulation of macrophages, while increased expression of CD206/MRC1 and Arg-1 is associated with IL-4 stimulation suggesting that myelin phagocytosis drives M(LPS) macrophages and microglia toward a M(IL-4) expression phenotype (according to the suggested new terminology). Myelin phagocytosis and internalization are required for changes in expression of these markers as detected using pHrodo-red-tagged myelin which fluoresces upon uptake into lysosomes (Kroner et al., 2014). More importantly, myelin phagocytosis reverses the LPS-induced cytotoxic effects of macrophages as determined in a neuronal cell death assay, and LPS-induced reduction of neurite growth from dorsal

root ganglion neurons in culture (Kroner et al., 2014). It therefore appears that phagocytosis of myelin by M (LPS) BMDMs and microglia reverses the LPS-mediated effects, and appears to push the cells toward a M(IL-4)like phenotype in vitro, which in the other terminology, would be a shift from M1 toward a M2 like phenotype. Myelin phagocytosis likely mediates its effects via multiple pathways. There is evidence, however, that myelin phagocytosis inhibits NF-jB activation (Kroner et al., 2014). There is also evidence that phagocytosis of myelin as well as liposomes containing phosphatidylserine (found in myelin) mediate reduction of nitric oxide, IL-6 in LPS-stimulated macrophages via activation of peroxisome proliferator-activated receptor b/d (PPAR b/d) (Bogie et al., 2013). Interestingly, treatment with phosphatidylserine containing liposomes is effective in reducing the severity of EAE (Bogie et al., 2013). It would appear then, that phagocytosis of myelin may be an endogenous mechanism to put the brakes on the acute inflammatory response and initiate repair processes. However, this switching-off of inflammation fails to occur in vivo in the injured spinal cord and possibly in other regions of the CNS as there is considerably stronger expression of markers associated with M(IFN-c) or M1 macrophages than M(IL-4) or M2 macrophages (Kigerl et al., 2009; Kroner et al., 2014). Our in vitro work shows that TNF contributes importantly to the failure of myelin phagocytosis to reduce expression of markers upregulated by LPS such as CD16/32 in both BMDMs and microglia (Kroner et al., 2014). Furthermore, there is an increase in the expression of the M(IL-4) markers Arg1 and CD206 in macrophages in the injured spinal cord of TNF null mice as compared to wild-type mice (Kroner et al., 2014). These changes are accompanied with improved locomotor recovery after SCI in TNF null mice. Similar changes in marker expression and functional improvement after SCI is seen in mitogenactivated protein kinase-activated protein kinase 2 (MK2) null mice (Ghasemlou et al., 2010; Kroner et al., 2014); MK2 is downstream of p38 MAPK and regulates TNF biosynthesis by targeting AU-rich elements (Winzen et al., 1999; Neininger et al., 2002). TNF expression at the protein level in the injured spinal cord is almost completely absent in MK2 null mice (Ghasemlou et al., 2010). Blocking TNF has also been shown to reduce damage and promote locomotor recovery after SCI (Novrup et al., 2014). TNF is expressed by macrophages (Pineau and Lacroix, 2007) and can thus have paracrine effects but it is also expressed by all other cell types in the injured spinal cord (Pineau and Lacroix, 2007). One of the ways in which this pro-inflammatory cytokine exerts its effects is by preventing the myelin phagocytosis-mediated change in phenotype that promotes resolution of inflammation. Cell culture work with BMDMs from wild-type and TNF null mice shows that 88% of the LPS-mediated increase in NOS2 expression and 97% of IL-12 expression is mediated via TNF. In vitro, myelin phagocytosis is able to prevent almost all of this LPS- induced increase in NOS2 and IL-12 via reducing the expression of TNF (Kroner et al., 2014). Likewise, much of the LPS-induced decrease in neurite growth from

Please cite this article in press as: David S et al. Macrophage and microglial plasticity in the injured spinal cord. Neuroscience (2015), http://dx.doi.org/ 10.1016/j.neuroscience.2015.08.064

364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424

NSC 16551

No. of Pages 8

5 September 2015

S. David et al. / Neuroscience xxx (2015) xxx–xxx 425 426 427 428 429 430 431 432 433 434 435 436 437 438

439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483

DRG neurons is mediated via TNF (as revealed in cultures of DRG from TNF null mice) which can be reversed by myelin phagocytosis (Kroner et al., 2014). However, as stated above, this effect of myelin phagocytosis to resolve inflammation is blocked in vivo in the injured spinal cord due to the presence of TNF produced by other cells in the injured CNS (Pineau and Lacroix, 2007), and possibly also by other cytokines. It is also important to note that in the context of EAE, soluble TNF promotes inflammation while membrane-bound TNF is neuroprotective (Taoufik et al., 2011). Earlier studies also showed that in EAE, demyelination but not inflammation is dependent on TNF receptor 1 (TNFR1) (Probert et al., 2000).

Effects of phagocytosis of apoptotic neutrophils by LPS-stimulated macrophages Earlier studies reported that phagocytosis of apoptotic cells (peripheral blood lymphocytes) by LPS-activated monocyte-derived macrophages led to increase in production of IL-10, and decrease in TNF, IL-1 and IL-12 (Voll et al., 1997). Other work has shown that LPS-stimulated macrophages that phagocytose neutrophils produce high levels of IL-10 upon re-stimulation (Filardy et al., 2013). In our hands phagocytosis of apoptotic neutrophils by LPS-stimulated BMDMs displayed noteworthy differences from similarly stimulated macrophages phagocytosing myelin (Kroner et al., 2014). While myelin phagocytosis markedly reduces the expression of TNF, IL-12, CD86 and CD16, neutrophil phagocytosis reduces expression of only TNF and CD86. In the context of CNS injury, reduction in TNF expression by these macrophages could have protective effects, however, it is not known if this change in phenotype is blocked in vivo in the CNS by cytokines. Neutrophils are the first line of defense against pathogens and microbes, and are the first cell type to enter sites of infection and injury (Mantovani et al., 2011; David et al., 2012b). They are attracted to the site of injury by chemokines, complement proteins and lipid mediators like leukotriene B4 (LTB4) (Serhan, 2010; Mantovani et al., 2011; Roth et al., 2014). Neutrophils can cause bystander damage to cells via release of proteases, reactive oxygen species, and pro-inflammatory cytokines. They enter the injured spinal cord within 24 h, reach peak numbers at 3–4 d and reduce markedly by 7–10 d (Kigerl et al., 2006; Stirling and Yong, 2008). There is some evidence that neutrophils cause tissue damage after SCI (Taoka et al., 1997; Naruo et al., 2003; Gris et al., 2004). A growing body of work suggests that the containment of neutrophil influx and phagocytosis of apoptotic neutrophils requires a class switch in the bioactive lipid mediators of inflammation from prostaglandins (PGE2, PGD2) and LTB4 produced during the acute phase to lipoxins and the synthesis of specialized proresolving lipid mediators (resolvins, protectins and maresins) arising from omega-3 fatty acids (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) (Serhan, 2010; David et al., 2012a). This response leads to the phagocytosis and clearance of neutrophils and resolution of inflammation. How effectively this lipid mediator class

5

switch and the synthesis of resolvins and protectins occurs after spinal cord injury is still not known.

484

Effects of phagocytosis of RBCs and uptake of iron by IL-4 and LPS-stimulated macrophages

486

Phagocytosis of RBCs by IL-4-stimulated BMDMs increases expression of the M(IFN-c) markers TNF, IL-12 and NOS2 (as well as CD16 and CD86), and decreases M(IL-4) markers CD206 and Ym1, indicating a shift in BMDMs from a M(IL-4) phenotype toward a M (IFN-c) phenotype (Kroner et al., 2014). TNF mediates about 2/3 of this effect, indicating a TNF-dependent and a smaller TNF-independent effect of RBC phagocytosis (Kroner et al., 2014). In contrast, phagocytosis of RBCs by LPS-stimulated BMDMs induces an additional 3-fold increase in IL-12 expression and does not significantly reduce the LPS- induced increase in TNF expression (Kroner et al., 2014). On the other hand, myelin phagocytosis by IL-4-stimulated macrophages does not affect the expression of these pro-inflammatory, cytotoxic markers (unpublished data; Kroner and David). Part of the effect of RBCs is thought to be caused by iron released from hemoglobin. Interestingly, unlike RBC phagocytosis by M(IL-4) BMDMs in vitro, internalization of iron dextran by these macrophages does not have any effect on expression of M(IFN-c) or M1 markers TNF, IL-12 NOS2, CD16 and CD86, however, it reduces expression of the M(IL-4) or M2 markers CD206 and Ym1 after 3 d in vitro (Kroner et al., 2014). In contrast to these in vitro effects, transplantation into the injured spinal cord of these IL-4-stimulated BMDMs loaded with RBCs or iron dextran both induced within 3 d a large increase in expression of TNF and decrease in CD206. This illustrates that M(IL-4) anti-inflammatory macrophages appear to convert to a pro-inflammatory state after phagocytosis of RBCs and uptake of iron. Iron can be released from dying RBCs or other cells at the site of CNS injury. In addition, iron uptake by LPS- stimulated macrophages increases TNF expression in vitro (Mehta et al., 2013). Thus iron can thus have serious negative implications for preventing the timely resolution of inflammation and lead to the continuance of chronic inflammation in the injured CNS. Macrophages can either take up RBCs and recycle the iron from hemoglobin as occurs in the spleen and reticuloendothelial macrophages or they can take up and sequester iron as occurs during infections to deprive bacteria of iron and thus exert a bactericidal effect. Iron sequestration under these conditions is regulated by hepcidin-mediated internalization, ubiquitination and degradation of the iron efflux transporter ferroportin (Nemeth et al., 2004). Iron accumulation in SCI and EAE is also thought to be mediated via hepcidin-mediated loss of ferroportin (Rathore et al., 2008; Zarruk et al., 2015). Iron is required for cell proliferation and tissue repair, and in the CNS it is also required for remyelination (Schulz et al., 2012). Iron accumulation in macrophages occurs in the injured spinal cord (Rathore et al., 2008; Kroner et al., 2014), and this accumulation leads to increased TNF expression in these cells and free radical generation in vivo (Kroner et al., 2014). Similarly,

488

Please cite this article in press as: David S et al. Macrophage and microglial plasticity in the injured spinal cord. Neuroscience (2015), http://dx.doi.org/ 10.1016/j.neuroscience.2015.08.064

485

487

489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543

NSC 16551

No. of Pages 8

5 September 2015

6

S. David et al. / Neuroscience xxx (2015) xxx–xxx

567

iron accumulation in macrophages in chronic skin ulcers induces pro-inflammatory macrophages with increased TNF expression and hydroxyl radical release (Sindrilaru et al., 2011). Iron accumulation in macrophages in SCI can therefore have multiple negative consequences, such as hampering tissue repair and remyelination, and have cytotoxic effects. These iron-mediated responses are also of relevance to brain trauma. Iron accumulation also occurs in the CNS in aging and a number of neurodegenerative diseases, such as amyotrophic lateral sclerosis (Jeong et al., 2009), Parkinson’s disease and Alzheimer’s disease (Zecca et al., 2004), multiple sclerosis (MS) and EAE (Hametner et al., 2013; Schuh et al., 2014; Zarruk et al., 2015). As in spinal cord injury, microglia and macrophages in MS and EAE lesions show iron accumulation, which can influence the cytotoxic properties of these cells. A subpopulation of microglia in the aging human brain show increased expression of the iron storage protein ferritin and display a dystrophic morphology that is increased in Alzheimer’s disease (Lopes et al., 2008). Similar dystrophic iron containing microglia are also seen in MS tissue (Hametner et al., 2013). Thus excessive iron accumulation in microglia can lead to microglial degeneration that may exacerbate the underlying pathology.

568

CONCLUSION

569

Microglia and macrophages are incredibly plastic cells that can change their phenotype from pro-inflammatory, cytotoxic to anti-inflammatory, pro-repair cells. In the injured CNS, this plasticity is influenced by what they phagocytose and by the cytokines and other factors in the environment. Although much is known about the antigenic phenotype of these cells, the field is moving beyond M1/M2 polarization to identification of more specific activation states that involve changes at the network level. This will require transcriptome analysis of purified microglia and macrophages from the injured spinal cord from different SCI models in different species. Relevant genes thus identified can be screened to probe for differences in treatment or other experimental manipulations and compared in network analysis to in vitro standards. This combined with a variety of functional assays will tightly correlate the expression phenotype to function. The field is headed in this direction. Understanding this will permit one to test strategies to effectively manipulate these cells to guide them to adopt a pro-repair phenotype that promotes recovery after CNS injury or disease.

544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566

570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590

595

Acknowledgments—Work done in SD’s laboratory that is presented in this review was supported by grants from the Canadian Institutes of Health Research (CIHR) (MOP-14828) and the Multiple Sclerosis Society of Canada. ADG and AK were both supported by CIHR Postdoctoral fellowships.

596

REFERENCES

597 598 599 600

Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM (2011) Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14:1142–1149.

591 592 593 594

Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM (2007) Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10:1538–1543. Alliot F, Godin I, Pessac B (1999) Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res 117:145–152. Bartus K, James ND, Didangelos A, Bosch KD, Verhaagen J, YanezMunoz RJ, Rogers JH, Schneider BL, Muir EM, Bradbury EJ (2014) Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury. J Neurosci 34:4822–4836. Bastien D, Lacroix S (2014) Cytokine pathways regulating glial and leukocyte function after spinal cord and peripheral nerve injury. Exp Neurol 258:62–77. Bogie JF, Jorissen W, Mailleux J, Nijland PG, Zelcer N, Vanmierlo T, Van Horssen J, Stinissen P, Hellings N, Hendriks JJ (2013) Myelin alters the inflammatory phenotype of macrophages by activating PPARs. Acta Neuropathol Commun 1:43. Boven LA, Van Meurs M, Van Zwam M, Wierenga-Wolf A, Hintzen RQ, Boot RG, Aerts JM, Amor S, Nieuwenhuis EE, Laman JD (2006) Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129:517–526. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL (2014) Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 17:131–143. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752–758. David S, Greenhalgh AD, Lopez-Vales R (2012a) Role of phospholipase A2s and lipid mediators in secondary damage after spinal cord injury. Cell Tissue Res 349:249–267. David S, Kroner A (2011) Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12:388–399. David S, Lopez-Vales R, Wee Yong V (2012b) Harmful and beneficial effects of inflammation after spinal cord injury: potential therapeutic implications. Handb Clin Neurol 109:485–502. Dibaj P, Nadrigny F, Steffens H, Scheller A, Hirrlinger J, Schomburg ED, Neusch C, Kirchhoff F (2010) NO mediates microglial response to acute spinal cord injury under ATP control in vivo. Glia 58:1133–1144. Donnelly DJ, Popovich PG (2008) Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209:378–388. Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, Kitazawa M, Matusow B, Nguyen H, West BL, Green KN (2014) Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82:380–397. Filardy AA, Pires DR, Nunes MP, Takiya CM, Freire-de-Lima CG, Ribeiro-Gomes FL, DosReis GA (2013) Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10 (high) regulatory phenotype in macrophages. J Immunol 185:2044–2050. Fuhrmann M, Bittner T, Jung CK, Burgold S, Page RM, Mitteregger G, Haass C, LaFerla FM, Kretzschmar H, Herms J (2010) Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer’s disease. Nat Neurosci 13:411–413. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71–82. Ghasemlou N, Lopez-Vales R, Lachance C, Thuraisingam T, Gaestel M, Radzioch D, David S (2010) Mitogen-activated protein kinaseactivated protein kinase 2 (MK2) contributes to secondary damage after spinal cord injury. J Neurosci 30:13750–13759. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M

Please cite this article in press as: David S et al. Macrophage and microglial plasticity in the injured spinal cord. Neuroscience (2015), http://dx.doi.org/ 10.1016/j.neuroscience.2015.08.064

601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671

NSC 16551

No. of Pages 8

5 September 2015

S. David et al. / Neuroscience xxx (2015) xxx–xxx 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741

(2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841–845. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35. Greenhalgh AD, David S (2014) Differences in the phagocytic response of microglia and peripheral macrophages after spinal cord injury and its effects on cell death. J Neurosci 34:6316–6322. Gris D, Marsh DR, Oatway MA, Chen Y, Hamilton EF, Dekaban GA, Weaver LC (2004) Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci 24:4043–4051. Haber M, Zhou L, Murai KK (2006) Cooperative astrocyte and dendritic spine dynamics at hippocampal excitatory synapses. J Neurosci 26:8881–8891. Hametner S, Wimmer I, Haider L, Pfeifenbring S, Bruck W, Lassmann H (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 74:848–861. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9:1512–1519. Heiman A, Pallottie A, Heary RF, Elkabes S (2014) Toll-like receptors in central nervous system injury and disease: a focus on the spinal cord. Brain Behav Immun 42:232–245. Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, Means TK, El Khoury J (2013) The microglial sensome revealed by direct RNA sequencing. Nat Neurosci 16:1896–1905. Hines DJ, Hines RM, Mulligan SJ, Macvicar BA (2009) Microglia processes block the spread of damage in the brain and require functional chloride channels. Glia 57:1610–1618. Jeong SY, Rathore KI, Schulz K, Ponka P, Arosio P, David S (2009) Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci 29:610–619. Katsumoto A, Lu H, Miranda AS, Ransohoff RM (2014) Ontogeny and functions of central nervous system macrophages. J Immunol 193:2615–2621. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29:13435–13444. Kigerl KA, McGaughy VM, Popovich PG (2006) Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol 494:578–594. Kroner A, Greenhalgh AD, Zarruk JG, Passos Dos Santos R, Gaestel M, David S (2014) TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 83:1098–1116. Lassmann H, Schmied M, Vass K, Hickey WF (1993) Bone marrow derived elements and resident microglia in brain inflammation. Glia 7:19–24. Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151–170. Lawson LJ, Perry VH, Gordon S (1992) Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48:405–415. Lopes KO, Sparks DL, Streit WJ (2008) Microglial dystrophy in the aged and Alzheimer’s disease brain is associated with ferritin immunoreactivity. Glia 56:1048–1060. Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11:519–531. Martinez FO, Gordon S, Locati M, Mantovani A (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177:7303–7311.

7

Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453–461. Mawhinney LA, Thawer SG, Lu WY, Rooijen N, Weaver LC, Brown A, Dekaban GA (2012) Differential detection and distribution of microglial and hematogenous macrophage populations in the injured spinal cord of lys-EGFP-ki transgenic mice. J Neuropathol Exp Neurol 71:180–197. Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A, Schmalbrock P, Pitt D (2013) Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One 8:e57573. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Bruck W, Priller J, Prinz M (2007) Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci 10:1544–1553. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, Mege JL, Mosser DM, Natoli G, Saeij JP, Schultze JL, Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel SN, Wynn TA (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41:14–20. Naruo S, Okajima K, Taoka Y, Uchiba M, Nakamura T, Okabe H, Takagi K (2003) Prostaglandin E1 reduces compression traumainduced spinal cord injury in rats mainly by inhibiting neutrophil activation. J Neurotrauma 20:221–228. Neininger A, Kontoyiannis D, Kotlyarov A, Winzen R, Eckert R, Volk HD, Holtmann H, Kollias G, Gaestel M (2002) MK2 targets AUrich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J Biol Chem 277:3065–3068. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–2093. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314–1318. Novrup HG, Bracchi-Ricard V, Ellman DG, Ricard J, Jain A, Runko E, Lyck L, Yli-Karjanmaa M, Szymkowski DE, Pearse DD, Lambertsen KL, Bethea JR (2014) Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice. J Neuroinflamm 11:159. Perry VH, Hume DA, Gordon S (1985) Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 15:313–326. Piccinini AM, Midwood KS (2010) DAMPening inflammation by modulating TLR signalling. Mediat Inflamm. Pineau I, Lacroix S (2007) Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500:267–285. Probert L, Eugster HP, Akassoglou K, Bauer J, Frei K, Lassmann H, Fontana A (2000) TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 123(Pt 10):2005–2019. Ransohoff RM, Cardona AE (2010) The myeloid cells of the central nervous system parenchyma. Nature 468:253–262. Rathore KI, Kerr BJ, Redensek A, Lopez-Vales R, Jeong SY, Ponka P, David S (2008) Ceruloplasmin protects injured spinal cord from iron-mediated oxidative damage. J Neurosci 28:12736–12747. Rigato C, Buckinx R, Le-Corronc H, Rigo JM, Legendre P (2011) Pattern of invasion of the embryonic mouse spinal cord by microglial cells at the time of the onset of functional neuronal networks. Glia 59:675–695. Roth TL, Nayak D, Atanasijevic T, Koretsky AP, Latour LL, McGavern DB (2014) Transcranial amelioration of inflammation and cell death after brain injury. Nature 505:223–228. Schuh C, Wimmer I, Hametner S, Haider L, Van Dam AM, Liblau RS, Smith KJ, Probert L, Binder CJ, Bauer J, Bradl M, Mahad D, Lassmann H (2014) Oxidative tissue injury in multiple sclerosis is

Please cite this article in press as: David S et al. Macrophage and microglial plasticity in the injured spinal cord. Neuroscience (2015), http://dx.doi.org/ 10.1016/j.neuroscience.2015.08.064

742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811

NSC 16551

No. of Pages 8

5 September 2015

8 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 867 868 869

S. David et al. / Neuroscience xxx (2015) xxx–xxx

only partly reflected in experimental disease models. Acta Neuropathol 128:247–266. Schulz K, Kroner A, David S (2012) Iron efflux from astrocytes plays a role in remyelination. J Neurosci 32:4841–4847. Serhan CN (2010) Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 177:1576–1591. Shechter R, Miller O, Yovel G, Rosenzweig N, London A, Ruckh J, Kim KW, Klein E, Kalchenko V, Bendel P, Lira SA, Jung S, Schwartz M (2013) Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 38:555–569. Sieger D, Moritz C, Ziegenhals T, Prykhozhij S, Peri F (2012) Longrange Ca2+ waves transmit brain-damage signals to microglia. Dev Cell 22:1138–1148. Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, Hainzl A, Schatz S, Qi Y, Schlecht A, Weiss JM, Wlaschek M, Sunderkotter C, Scharffetter-Kochanek K (2011) An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. Stirling DP, Yong VW (2008) Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res 86:1944–1958. Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M, Naruo M, Okabe H, Takatsuki K (1997) Role of neutrophils in spinal cord injury in the rat. Neuroscience 79:1177–1182. Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, Szymkowski DE, Probert L (2011) Transmembrane tumour

necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factorkappaB. Brain 134:2722–2735. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I (1997) Immunosuppressive effects of apoptotic cells. Nature 390:350–351. Wes PD, Holtman IR, Boddeke EW, Moller T, Eggen BJ (2015) Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease. Glia. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB, Muller M, Gaestel M, Resch K, Holtmann H (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18:4969–4980. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, De Nardo D, Gohel TD, Emde M, Schmidleithner L, Ganesan H, Nino-Castro A, Mallmann MR, Labzin L, Theis H, Kraut M, Beyer M, Latz E, Freeman TC, Ulas T, Schultze JL (2014) Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40:274–288. Zarruk JG, Berard JL, Passos Dos Santos R, Kroner A, Lee J, Arosio P, David S (2015) Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation. Neurobiol Dis. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863–873.

(Accepted 25 August 2015) (Available online xxxx)

Please cite this article in press as: David S et al. Macrophage and microglial plasticity in the injured spinal cord. Neuroscience (2015), http://dx.doi.org/ 10.1016/j.neuroscience.2015.08.064

840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866